Table 1

- Patient’s summarized timeline.

DatesRelevant past medical history and interventions
Diagnostic testingIntervention
March 2017Adalimumab was considered, but latent tuberculosis was detectedFull anti-tuberculosis regimen
December 2018Purified protein derivative test was negativeAdalimumab was initiated
January 2020-Adalimumab was discontinued due to reoccurring spikes of fever
August 2020 (At the time of patient presentation)Renal function test showed elevated serum creatinine and urine protein. Renal biopsy showed stage V chronic kidney disease secondary to advanced renal amyloidosisPrednisolone, and reintroduction of adalimumab was considered to treat both his HS and renal amyloidosis. The patient was also referred to general surgery to manage his genital lymphedema.

HS: hidradenitis suppurativa